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An electrophoretically unique, thermolabile isozyme of  triosephosphate 
isomerase (TPI; EC 5.3.1.1) accounts for 10-30% of the enzymatic activity 
in a range of  mitotically active human cells and tissues. This type 2 form 
(subunit) of  human TPI appears in two isozymes, an anodally migrating, 
relative to the constitutive TPI-1/I homodimer, TPI-2/2 homodimer and the 
TPI-I/2 heterodimer with an intermediate mobility. Human cell types 
expressing the induced isozyme, which is the product of  the same structural 
locus as the constitutive isozyme, include mitogen-stimulated lymphocytes, 
virally transformed B-lymphoblastoid cells, leukemia-derived T-lympho- 
blastoid cells, HeLa cells, both normal and transformed fibroblasts, and 
placental tissue. Extracts of  nondividing or terminally differentiated human 
cells~tissues, such as erythrocytes, striated muscle, peripheral lymphocytes, 
and platelets, contain high levels of  the constitutive TPI-1/1 isozyme but 
little or undetectable levels of  the TPI-1/2 or TPI-2/2 isozyme. The cell 
division-associated TPI-1/2 and -2/2 isozymes are distinct in electrophoretic 
mobility from the deamidated forms of  the constitutive isozyme. Extracts of  
dividing gorilla fibroblasts display an isozyme pattern identical to that of  
proliferating human cells, but various proliferating cells derived from the 
African green monkey, rabbit, and chicken express only the constitutive 
isozyme. Thus, expression of  the cell division-associated isozyme o f  TPI is 
restricted to the hominoids, suggesting a recently evolved modification 
mechanism which is specifically activated in proliferating cells. 
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INTRODUCTION 
Multiple isozymes, different molecular forms of an enzyme as described by 
Markert (1974), are observed for many enzymes following electrophoresis of 
cell and tissue extracts. These multiple forms include allelic variants, gene 
products of duplicated structural loci, or electromorphs which result from 
spontaneous aging of the primary isozyme (Harris, 1980). Isozymic forms 
may also be generated by specific posttranslational events such as proteolytic 
cleavage and covalent ligand binding (see Wold, 1981) and noncovalent 
binding of cofactors (Dreyfus et al., 1978). In addition to posttranslational 
events, examples of multiple isozymes from a single structural locus have now 
been shown to be produced by (1) gene reorganization (Early et al., 1980; 
Nasmyth and Tatchell, 1980) and (2) differential transcript processing 
(Crabtree and Kant, 1982; Marie et al., 1982; Young et al., 1981; Levin et al., 
1982; Capetanaki et al., 1983; Schwarzbauer et al., 1983; Nabeshima et al., 
1984). 
Triosephosphate isomerase (TPI; EC 5.3.3.1), a dimeric molecule of 
identical subunits of 26,000-27,000 daltons is one enzyme where multiple 
isozyme forms are observed following electrophoresis of extracts from tissues 
from a range of species (Scopes, 1968; Snapka et al., 1974). Several 
mechanisms are known to account for the electrophoretic multiplicity of 
human TPI. A series of anodally migrating isozymes of TPI, which are 
constitutively expressed in all human cells, has been shown to originate via 
sequential deamidations of asparagine residues at positions 15 and 71 (Gracy 
and Yuan, 1980). Consistent with this observation is the presence of these 
isozymes in rabbit TPI (Corran and Waley, 1975) but not in the chicken 
enzyme (Putnam et al., 1972), where a lysine residue occupies position 71 
(Banner et al., 1975). Allelic variation has also been reported, but the 
frequency of mobility variants, at least in humans, is very low (Harris et al., 
1974; Neel et al., 1980a,b). 
An additional, thermolabile, anodally migrating form of the human 
enzyme has been observed in mitogen-stimulated lymphocytes (Decker and 
Mohrenweiser, 1981; Kester and Gracy, 1975; Rogers et al., 1980). This 
isozyme has structural and kinetic properties which are very similar to those 
i observed for the constitutive isozyme (Kester et al., 1977; Yuan et al., 1970). 
Dreyfus and co-workers have also identified electrophoretically distinct 
isozymes in human fibroblasts (Rubinson et al., 1971) and have reported that 
these isozymes are detectable only in fibroblasts derived from hominoid 
species (Rubinson et al., 1973). Although these isozymes were initially 
proposed to be the product of a second structural locus (Kester et al., 1977; 
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Yuan et al., 1979), subsequent genetic studies have demonstrated that the 
constitutive isozyme (TPI-1 subunit) and the thermolabile, cell division- 
associated isozyme (TPI-2 subunit) are actually products of the same 
structural locus (Decker and Mohrenweiser, 1981). 
The present study expands our previous work on the expression and 
identity of the TPI-2 isozyme. The examination of a series of normal and 
transformed cell lines of human and nonhuman origin defines the range of 
TPI-2 expression and correlates TPI-2 expression with the general state of 
cellular proliferation. The restricted pattern of expression found for the TPI-2 
isozyme contrasts with the wide distribution, both within and between species, 
which is observed for the TPI-1 isozyme and its associated deamidated forms. 
An increase in electrophoretic resolution has allowed us to clearly establish 
the nonidentity of the TPI-1/2 isozyme with the deamidation products of the 
TPI-1/1 isozyme and to demonstrate the presence of the rapidly migrating 
TPI-2/2 isozyme in stimulated lymphocytes and placenta. 
MATERIALS AND METHODS 
The electrophoretic techniques were as described by Decker and Mohren- 
weiser (1981) except that the polyacrylamide gel dimensions were 16.0 x 
18.0 x 0.15 cm. TPI activity was detected using 6 mM dihydroxyacetone 
phosphate-lithium (Sigma, St. Louis, Mo.) as substrate. Cellulose acetate 
strips (Gelman, Ann Arbor, Mich.) were soaked in staining solution and 
overlayed on the gel, which was incubated at 37°C. The reaction was stopped 
by fixing the strips in 7% acetic acid, usually after 15 min; 5- and 30-rain 
incubation times were also used to monitor the intensity of the prominent 
bands and to facilitate the search for additional weakly staining bands. 
The B-lymphoblastoid cell line (UM-121) was derived from a heterozy- 
gous individual with the TPI-N/Manchester genotype (Asakawa and Moh- 
renweiser, 1982; Decker and Mohrenweiser, 1981) and was established via the 
viral transformation procedure of Yamamota and zurHansen (1979). The 
human B-lymphoblastoid cell line, UM-61, was described by Choi and Bloom 
(1970). Four additional, virally transformed, human B-lymphoblastoid cell 
lines (KC, ES, IV, and LP), as well as two human B-lymphoblastoid cell lines 
(MGL-8 and GM-130) and two leukemia-derived human T-lymphoblastoid 
cell lines (MOLT-4 and CEM-CCRF), were supplied by Dr. P. Daddona, 
Department of Internal Medicine, University of Michigan (UM). The normal 
human fibroblast cells, DA-S and GM-41, were obtained from Dr. C. W. 
Castor (Department of Internal Medicine, UM) and Dr. J. Thoene (Depart- 
ment of Pediatrics, UM). The chemically transformed human fibroblasts, 
HUT-l-11, were from Dr. T. Featherstone and the HeLa derivative (TK-, 
BU-25) was from Dr. B. Wu, both of the Department of Human Genetics, 
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UM. The normal gorilla fibroblasts (TCH 3228) were from Dr. T. C. Hsu of 
the Department of Cell Biology, M. D. Anderson Hospital and Tumor 
Institute, Houston, Tex. The transformed African green monkey (Ceropithe- 
cus aethiops) kidney cell line, Veto, and the primary rabbit kidney cells were 
from Dr. R. Sandri-Goldin of the Department of Human Genetics, UM. The 
primary human and rabbit lymphocytes were isolated and cultured as 
previously described by Decker and Mohrenweiser (1981). Platelets were 
isolated by differential centrifugation (Long et al., 1985). All lysates of 
cultured cells as welt as extracts of placental and muscle tissue were prepared 
as described by Decker and Mohrenweiser (1981). 
RESULTS 
The electrophoretic patterns for TPI activity from human erythrocytes, 
peripheral lymphocytes, and mitogen-stimulated lymphocytes, from both a 
normal (TPI-N/N) and a heterozygous variant (TPI-N/Manchester) TPI 
phenotype individual, are shown in Fig. 1. The erythrocyte isozyme patterns 
for the individual with the normal phenotype (lane 6) and the heterozygous 
TPI-N/Manehester individual (lane 5) are as previously described (Asakawa 
and Mohrenweiser, 1982). The difference between the pattern in erythrocytes 
and that in lymphoeytes (lanes 3 and 4) presumably reflects the aging process 
of erythrocyte TPI via deamidation of the primary isozyme (Gracy and Yuan, 
1980). The TPI-N/Manchester pattern is consistent with the dimeric subunit 
structure of this enzyme. 
The TPI isozyme pattern in extracts of mitogen-stimulated lymphocytes 
for an individual with a normal phenotype (lane 2) is characterized by the 
appearance of additional, anodally migrating bands as described previously 
(Decker and Mohrenweiser, i981). An additional isozyme band, with a 
mobility approximately similar to that of the isozyme having undergone four 
deamidations (Gracy and Yuan, 1980) and termed TPI-A in recent reports 
(Kester and Gracy 1974; Kester et al.. 1977; Decker and Mohrenweiser, 
1981), is observed in the stimulated lymphocytes (lane 2). Another even more 
anodally migrating isozyme band becomes detectable when the level of 
enzymatic activity applied to the gel is increased or the staining time is 
lengthened. 
The variant pattern of mitogen-induced TPI isozymes, including the 
rapidly migrating 2N2N and 2N2M allozymes, can be seen in lane 1. Equal 
amounts of enzyme activity were electrophoresed in samples 1 through 4 to 
allow a comparison of the relative staining intensity of the individual 
isozymes. The single structural TPI gene model is supported by (1) a lessened 
staining intensity in the 2N2N position and (2)the appearance of allozymes 
unique to the variant phenotype in the 2N2M and 1M2M positions. Some of 
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Fig. 1. Electrophoretic analysis of human triosephosphate isomerase isozymes. The 
samples in lanes l, 3, and 5 are from a heterozygous individual with a TPI-N/ 
Manchester phenotype, while the samples in lanes 2, 4, and 6 are from an individual 
with a TPI-N/N phenotype. Lanes 1 and 2 are lymphoblasts after 75br of phytohe- 
magglutinin stimulation, lanes 3 and 4 are peripheral lymphocytes, and lanes 5 and 6 
are erythrocytes. Enzymatic activity was detected as described in Materials and 
Methods. 
the  d imer ic  a l lozymes which contain  a 2M subuni t  are  predic ted  to comigra te  
with isozymes composed of  two normal  subunits  (see Fig. 2). In the case of 
1 N 1 N  and 1 M 2 M ,  resolut ion of these a l lozymes  was achieved by extending 
the migra t ion  d is tance  (Decker  and Mohrenweiser ,  198 I).  
A schemat ic  of the  e lec t rophore t ic  pa t te rns  is presented in Fig. 2. The  
const i tut ive TPI  subuni ts  a re  des ignated  " 1 "  and the thermolabi te ,  mi togen-  
induced TPI  subunits  a re  des ignated  "2 , "  The  " N "  and " M "  nomencla ture  
represents  the  normal  and Manches t e r  var iant  subuni ts ,  respectively.  As seen 
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Fig. 2. Schematic representation of triosephosphate isom- 
erase isozymes from Fig. 1. "1" indicates TPI-1 subunits 
and "2" indicates TPI-2 subunits, while "N" indicates 
normal subunits and "M" indicates Manchester variant 
subunits. ( IS] ) Constitutive isozyme; ( • ) cell divi- 
sion-associated isozymes; ( [ ]  ) deamidated forms of 
constitutive isozymes; (Note: lanes 1 and 4 are reversed 
from Figure 1). 
in lane 2 of Fig. 2, the pattern is that expected for a dimeric enzyme formed 
from two types of subunits. The present designation of the TPI-A or -1/2 
isozyme as a heterodimer, in contrast to a homodimeric molecule (Decker and 
Mohrenweiser, 1981), results from the identification of the anodal 2 /2  
isozyme (Figs. 1 and 2). Additionally, the results of isoelectricfocusing 
experiments of the purified isozymes, conducted in the presence of 8 M urea, 
indicate a homodimeric subunit structure for TPI  1/1, while the isozyme 
designated TPI  1/2 is composed of two types of subunits, one being the TPI  1 
subunit, (Decker and Mohrenweiser, 1983; Decker and Mohrenweiser, in 
preparation). The genetic origins of the TPI-1 and -2 subunits are still 
interpreted as a single structural locus when viewed in terms of a TPI-1 /1 ,  
-1/2, and -2/2 isozyme pattern. 
The TPI -1 /2  heterodimer was detected in a wide range of cultured 
human cells. It was detected in nine different transformed human B- 
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lymphoblastoid lines and in two leukemia-derived human T-cell lines. TPI- 
1/2 was also present in the extracts of both normal and transformed human 
fibroblast cell lines. Thus, the expression of the TPI-2 subunit appears to be a 
general property of cells active in cell division rather than an association with 
specific cell types or tissues. 
The electrophoretic profile of the TPI isozymes was also examined in 
several differentiated human tissues and cells (Fig. 3). Similar patterns were 
observed in hemolysate (lane 1) and striated muscle extract (lanes 2 and 9), 
with some 8-10 bands of TPI activity being detectable. The activity bands 
immediately anodal to the constitutive TPI-1 isozyme are designated TPI-1', 
-1", etc. [corresponding to bands b-e of Peters et al. (1973)], and have been 
demonstrated to be the products of spontaneous deamidation (Gracy and 
Yuan, 1980). Peripheral lymphocytes (lane 7) and platelets (lane 8) exhibit a 
pattern of a major band, which is identical in mobility to the major band in 
muscle and erythrocyte, but only a weak staining intensity is observed in the 
position of the TPI-1' through -1" isozymes. The isozyme pattern of placenta 
is similar to that of stimulated lymphocytes; the TPI-1/1 and TPI-1/2 bands 
are the most intensely staining. Also, the proposed TPI-2/2 homodimer is 
clearly visible in placental extract (lane 10). In experiments not presented 
here, the TPI-2/2 isozyme is also observed in the lymphoblastoid cells when 
large amounts of extracts are electrophoresed. 
A comparison of the TPI isozymes arising via deamidation in placentae 
and muscle shows identical comigration in both samples; however, the 
TPI-I"/I"  band, quite pronounced in muscle extract (lane 11) and barely 
apparent in placental tissue, clearly has a different rate of electrophoretic 
migration than the TPI-1/2 isozyme of placentas (lane 10). The high amounts 
of TPI in striated muscle allow the visualization of a large number of human 
TPI isozymes including very low levels of the TPI-1/2 isozyme, which again 
confirms that the TPI-1/2 and TP1-1"/1" isozymes are distinct and separate 
isozymes. The electrophoretic profile of the TPI isozymes from erythrocytes, 
stimulated lymphocytes, and muscle is presented schematically in Fig. 4. 
During the course of these studies we sought to reexamine the phyloge- 
netic range of expression of the TPI type 2 subunit. An earlier observation by 
Dreyfus and coworkers (1973) indicated that their "intermediate" and "very 
fast" isozymes were not found in primary fibroblast cultures of nonhominoid 
primates or lower mammals. 
As seen in Fig. 5, fibroblasts derived from the gorilla (lane 3) have 
isozymes with mobilities similar to those of both the TPI- 1/1 and the TPI- 1/2 
isozymes from transformed human lymphoblasts (lane 2). A band comigrat- 
ing with TPI-2/2 is also observed but only after prolonged staining. In 
contrast, extracts of rapidly dividing African green monkey kidney (lane 4) 
exhibit only a single prominent band of TPI activity which comigrates with 
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Fig. 4. Schematic representation of TPI isozymes 
from Fig. 3. Lane 1 is erythrocytes, lane 2 is trans- 
formed lymphoblasts, and lane 3 is muscle extract. (9 
the TPI-1/1 isozyme of human and gorilla and two minor bands which are 
presumably the first two deamidation bands of TPI- 1 / 1. The pattern observed 
with extracts of mitogen-stimulated rabbit lymphocytes (lanes 6 and 8) and 
cultured primary rabbit kidney cells (lane 7) indicates a single major isozyme 
and minor associated bands, presumably arising via spontaneous deamidation. 
All of these cells had growth characteristics similar to those of the comparable 
human cell, thus differences are not a reflection of differences in culture 
conditions or growth rates. The pattern in both of the rabbit cell types is 
identical to that detected in unstimulated rabbit lymphocytes (lane 5). It 
should be noted that the TPI isolated from rabbit and human differ by only 
some 12 residues and both enzymes contain the labile asparagine residues 
(Oray et al., 1983). In further studies, only a single band of enzyme activity 
was detected in chicken B- and T-lymphoblast cells (data not shown). The 
lack of deamidation products is consistent with the replacement of lysine for 
asparagine in the 15th position of chicken TPI and the model of sequential 
deamidation proposed by Yuan et al. (1983). Thus, in none of the extracts of 
rapidly dividing cells from the green monkey, rabbit, or chicken is an isozyme 
found which is analogous to the human proliferation-specific, TPI-1/2 
isozyme. This is in contrast to the observations from the proliferating human 
and gorilla cells which contain high levels of the TPI-1/2 isozyme. The 
phylogenetic expression data are summarized in Table I. 
DISCUSSION 
The thermolabile TPI-1/2 isozyme accounts for approximately 50% of the 
enzyme activity in human lymphocyte cells after 72 hr of mitogen stimulation 
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Fig. 5. Electrophoretic analysis of triosephosphate isomerase isozymes in several species. 
Samples are (lane 1) human muscle, (lane 2) transformed human lymphoblasts, (lane 3) 
gorilla fibroblasts, (lane 4) African green monkey kidney cells, (lane 5) rabbit peripheral 
lymphocytes, (lanes 6 and 8) rabbit primary lymphoblasts, and (lane 7) rabbit primary 
kidney cells. 
(Decker and Mohrenweiser, 1981) and approximately 20% of the total TPI 
activity in several asynchronously dividing, virally transformed lymphoblas- 
toid cell lines (Decker and Mohrenweiser, in preparation). The TPI-1/2 
isozyme is detectable in a wide range of cultured human cells, including 
normal as well as chemically and virally immortalized cells. TPI-1/2 is also 
present in placental extracts but is absent in erythrocytes and platelets and 
only barely detectable in extracts of striated muscle, which is consistent with a 
relationship of TPI-1/2 expression and cell division. Thus, this isozyme does 
not appear to be associated with specific differentiation processes but rather is 
the result of a process which occurs during cell growth and division. 
In contrast to the general nature of TPI-1/2 expression in various 
proliferating human cells, the expression of TPI-1/2 is restricted to proliferat- 
ing cells derived only from the hominoid species. The detection of the TPI-1/2 
isozyme in cultured cells from gorilla and the complete absence of a 
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Table I, Qualitative TPI Isozyme Analysis of Cells in Culture a 
Isozymic form 
Cell type T P I - 1 / 1  T P I - I ' / 1  TPI-t/2 
Human primary lymphoblasts ( N  - 2) + 
Human B-cell lymphoblasts, transformed 
( N  = 9) + 
Human T-cell lymphoblasts, leukemia de- 
rived ( N  = 2) + 
Human fibroblast, normal ( N  = 2) + 
Human fibroblast, transformed + 
Human carcinoma ( H e L a )  + 
Gorilla fibroblast, normal + 
African green monkey kidney, transformed + 
Rabbit kidney, primary + 
Rabbit lymphoblast, primary + 
Chicken B-cell lymphoblasts + 











a ( + ) Present;  ( - )  absent .  TPI -  1 / 1 is the constitutive isozyme, TPI-  1'/1 is the first deamidation 
product of the constitutive isozyme, and TPI-I/2 is the heterodimer isozyme composed of one 
constitutive and one cell division-associated subunit. 
TPI-1/2-like isozyme in transformed African green monkey cells and in two 
types of primary rabbit-cell cultures are in complete agreement with the 
previous observations (Rubinson et al., 1972). These workers found an 
analogous TPI isozyme in fibroblast explant cultures of various hominoid 
species but not in fibroblasts of lower primates or other mammals. The 
phylogenetic restriction of TPI-1/2 is in contrast to the situations described 
for other tissue or cell type-specific isozymes. For example, pyruvate kinase 
undergoes a tissue-specific modification in mice and rats, as well as humans 
(Marie et al., 1981; Sakeki, 1982a,b), and placental alkaline phosphatase 
appears to have a diverse and complex pattern of phylogenetic expression 
within lower and higher primates (Goldstein et al., 1982). 
In the present paper, we have introduced a new isozyme nomenclature for 
human TPI. The necessity for a new nomenclature is based on two findings. 
First, we have identified a band of TPI activity in stimulated lymphocytes, 
placenta, and concentrated lymphoblastoid extracts which migrates in a 
position identical to that predicted for a mitogen-induced TPI-2/2 homodi- 
mer. However, Kester et al. (1977) found no evidence for such an isozyme and 
described only a single new isozyme (TPI-A) in proliferating lymphocytes and 
fibroblast cultures. Our results demonstrate that at least low levels of the more 
anodal TPI-2/2 isozyme are present in stimulated lymphocytes, placenta, and 
long-term lymphoblastoid cells. An examination of the isozyme pattern in 
both stimulated lymphocytes and long-term B-lymphoblastoid cells, which 
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were obtained, or derived, from an individual with the Manchester variant 
phenotype, fully supports our previous model for a single structural locus 
encoding both TPI-1 and TPI-2. The levels of the TPI-2/2 isozyme are low in 
all cells and tissues where it is present. The non-steady-state conditions of 
72-hr mitogen-stimulated primary lymphocytes make it difficult to predict 
dimeric isozyme ratios for randomly assorting type 1 and type 2 subunits. 
However, the long-term lymphoblastoid cultures provide a convenient steady- 
state system. Heat denaturation assays of the UM61 line indicate a 4:1 ratio 
of TPI-1/I:TPI-1/2 + 2/2. Random assortment of types 1 and 2 subunits 
would thus predict on 81:18:1 isozyme ratio for the 1/1:1/2:2/2 dimers; 1% 
levels for TPI-2/2 in these cells are consistent with that observed with isozyme 
activity staining. Second, in experiments to be published elsewhere, purified 
isozymes were subjected to isoelectric focusing in the presence of 8 M urea. 
The results indicate that the isozyme which we and others (Decker and 
Mohrenweiser, 1981; Kester et al., 1976) had previously designated the TPI-A 
homodimer is in fact composed of a constitutive subunit (type 1) and a cell 
division-associated TPI subunit, which we now designate type 2. 
The absence of the TPI-1/2 isozyme from the cultured green monkey 
and rabbit cells supports our conclusion that the TPI-2 subunit does not arise 
due to spontaneous deamidation. Both the green monkey and the rabbit cells 
contain the initial deamidation isozymes -1/1' and -1'/1', and green monkey 
hemolysates exhibit a TPI isozyme pattern identical to that of human 
erythrocytes (Figs. 3 and 6; Turner et al., 1984). Also, the rabbit enzyme has 
been shown to have the labile aspargines in positions 15 and 71, as does the 
human enzyme (Yuan et al., 1981). The nonidentity of TPI-1/2 and the 
closely migrating 1"/1" deamidation isozyme is supported by a comparison of 
placental and muscle, or erythrocyte extracts. The deamidation isozymes, 
-1/1' through -1"/1", have identical rates of migration in both tissue extracts, 
however, TPI-1/2 clearly has a faster rate of migration than TPI-I"/I".  
Further, Gracy and co-workers have demonstrated the subunit structure of 
TPI-I" / I"  to be a homodimer of doubly deamidated subunits (Yuan et al., 
1981), while our evidence suggests a heterodimeric structure for TPI-1/2 
(Decker and Mohrenweiser, 1983). 
In keeping with the conclusion that a single structural gene encodes these 
isozymes, we have previously suggested that the cell division-associated TPI-2 
subunit is a modified form of the constitutive TPI- 1 subunit. The restriction of 
TPI-2 to hominoids implies specificity of the modification event. This is 
especially compelling in view of the conservative nature of the TPI structure. 
This phylogenetic restriction reinforces the genetic basis for the proposed 
modification and suggests a recently evolved regulatory mechanism which 
may represent an alternative strategy to gene duplication for evolution of 
protein structure and function. Further work is in progress which should 
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elucidate the regulatory and structural basis for this cell cycle-associated 
isozyme. 
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